The evidence for probiotic strain specificity
Navigate the appropriate use of strain-specific, disease-specific probiotics in clinical practice; assess the evidence supporting optimised gut health to aid symptomatic management and treatment of GIT infections and complaints
Learning objectives
You will learn:
- The rapid growth in gut microbial research and heightened awareness of gut health have led to a significant increase in probiotic products, making it challenging for health practitioners to navigate the evidence and determine appropriate probiotic prescriptions for clinical treatment
- Probiotics are strain-specific and disease-specific
- Bigger does not mean better when looking at colony-forming unit (CFU) counts
- This report puts three different probiotic strains under the microscope and assesses their use in clinical practice
- Are we there yet? Considerations for strain-specificity in clinical practice.
To access this module, please register or login: